Boston Financial Mangement LLC Eli Lilly & CO Transaction History

Boston Financial Mangement LLC

$3.23 Billion
Q3 2024

A detailed history of Boston Financial Mangement LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Boston Financial Mangement LLC holds 5,020 shares of LLY stock, worth $3.75 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,020

Previous 5,007 0.26%

Holding current value

$3.75 Million

Previous $4.53 Million 1.9%

% of portfolio

0.14%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $10,037 - $12,480	13 Added 0.26%	5,020 $4.45 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $26,820 - $33,634	-37 Reduced 0.73%	5,007 $4.53 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $13,028 - $17,430	-22 Reduced 0.43%	5,044 $3.92 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $132,347 - $156,020	-252 Reduced 4.74%	5,066 $2.95 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $15,214 - $20,975	-35 Reduced 0.65%	5,318 $2.86 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $224,824 - $300,616	-641 Reduced 10.69%	5,353 $2.51 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $19,569 - $22,983	-63 Reduced 1.04%	5,994 $2.06 Million
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $75,242 - $87,672	-234 Reduced 3.72%	6,057 $0
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $45,064 - $51,356	152 Added 2.48%	6,291 $2.03 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $8,361 - $9,818	-30 Reduced 0.49%	6,139 $1.99 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $63,600 - $79,039	271 Added 4.59%	6,169 $1.77 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $14,615 - $18,137	65 Added 1.11%	5,898 $1.63 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $260,380 - $320,434	1,175 Added 25.23%	5,833 $1.35 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $5,416 - $7,006	30 Added 0.65%	4,658 $1.07 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $30,234 - $39,140	184 Added 4.14%	4,628 $865,000
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $8,928 - $11,051	75 Added 1.72%	4,444 $616,000
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $23,094 - $28,604	-216 Reduced 4.71%	4,369 $574,000
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $854 - $929	-8 Reduced 0.17%	4,585 $513,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $40,105 - $46,813	-362 Reduced 7.31%	4,593 $509,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $83,927 - $98,789	-754 Reduced 13.21%	4,955 $643,000
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $101,028 - $113,182	954 Added 20.06%	5,709 $661,000
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $7,212 - $9,014	-84 Reduced 1.74%	4,755 $510,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $5,299 - $6,081	-70 Reduced 1.43%	4,839 $413,000
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $28,924 - $31,025	-353 Reduced 6.71%	4,909 $415,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $405,542 - $450,111	5,262	5,262 $450,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Eli Lilly & CO Transaction History